In line with negative transcriptional and posttranslational control of EGFR signals via ERK, recent siRNA screens and systems biology approaches have revealed that EGFR signal re-activation plays an important role in resistance to MEK blockade in CRC cells [110, 111]. This evidence concerns the gene MAP2K7 and colorectal carcinoma.